WORLDWIDE‑CORRUPTION

China · Findings · Subsidiary of a US issuer (Exhibit 21)

GEHC · Ex21

Why it is here

Indicator “Subsidiary of a US issuer (Exhibit 21)” computed from public data: GEHC · Ex21 — buyer 广州医科大学附属肿瘤医院, USD 16,500,000.

Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.

Details

Company / subject
GEHC · Ex21
Buyer
广州医科大学附属肿瘤医院
Indicator
Subsidiary of a US issuer (Exhibit 21)
Amount
USD 16,500,000
Records behind the indicator
1
Found
4 October 2026
Code
CN-12419
Reference
2026-02-04
Reference
0001932393-26-000007

Other records of this company86

  1. 017 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  2. 027 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  3. 036 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  4. 046 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  5. 055 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  6. 065 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  7. 075 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  8. 085 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  9. 095 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  10. 104 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
All 86
  1. 114 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  2. 124 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  3. 134 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  4. 144 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  5. 154 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  6. 164 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  7. 174 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  8. 184 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  9. 194 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  10. 204 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  11. 214 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  12. 224 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  13. 234 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  14. 244 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  15. 254 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  16. 264 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  17. 274 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  18. 284 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  19. 294 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  20. 304 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  21. 314 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  22. 324 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  23. 334 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  24. 344 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  25. 354 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  26. 364 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  27. 374 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  28. 384 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  29. 394 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  30. 404 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  31. 414 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  32. 424 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  33. 434 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  34. 444 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  35. 454 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  36. 464 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  37. 474 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  38. 484 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  39. 494 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  40. 504 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  41. 514 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  42. 524 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  43. 534 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  44. 544 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  45. 554 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  46. 564 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  47. 574 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  48. 584 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  49. 594 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  50. 604 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  51. 614 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  52. 624 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  53. 634 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  54. 644 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  55. 654 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  56. 664 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  57. 674 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  58. 684 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  59. 694 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  60. 704 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  61. 714 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  62. 724 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  63. 734 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  64. 744 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  65. 754 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  66. 764 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  67. 774 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  68. 784 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  69. 794 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  70. 804 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  71. 814 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  72. 824 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  73. 834 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  74. 844 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  75. 854 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)
  76. 864 October 2026Findings · Subsidiary of a US issuer (Exhibit 21)

JSONFindings · Subsidiary of a US issuer (Exhibit 21)